FENOPROFEN CALCIUM

Post-LOE

fenoprofen calcium

ANI Pharmaceuticals

ANDAORALTABLET

Approved

May 1988

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

FENOPROFEN CALCIUM (fenoprofen calcium) by ANI Pharmaceuticals is analgesic, anti-inflammatory, and antipyretic properties. Approved for rheumatoid arthritis. First approved in 1988.

Drug data last refreshed 20h ago

Mechanism of Action

analgesic, anti-inflammatory, and antipyretic properties. The mechanism of action of FENOPROFEN CALCIUM, like that of other NSAIDs, is not completely understood but involves inhibition of cyclooxygenase (COX-1 and COX-2). Fenoprofen is a potent inhibitor of prostaglandin synthesis in vitro.…

Indications (1)

rheumatoid arthritis

Company

Worked on FENOPROFEN CALCIUM at ANI Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.